Restaging w/ #PSMA Imaging in #mCRPC #ProstateCancer: When Seeing More Is Detrimental to Care Sadly a year later this remains true & the frequency of this is 📈 @ascocancer.bsky.social @ascopost.bsky.social ascopubs.org/doi/pdf/10.1...

🗣️"The system is horribly broken & it hurts patients unnecessarily” 🗣️"They wrote me off as a dead man”   Navigating #priorauth requires tech savvy, an understanding of insurance processes, knowledge of personal rights, & time to engage in the process.   @ascocancer.bsky.social @astro-org.bsky.social

Shout out to the WSJ journalists who reported on Vought’s impoundment by footnote, causing the White House to walk it back. Impact journalism!!

Such an honor and so much fun to join the Cancer Clear and Simple @uwhealth.bsky.social Carbone Cancer Center Podcast to discuss liquid biopsies in cancer! cancer.wisc.edu/community-ou...

"We cure a lot of diseases, & we create a lot of medical debt. It’s a push/pull; right? The advances that we have within science & medicine are profound. We have people living longer & better. Yet, the cost of treatment is a side effect like any other." #financialToxicity @cancerletter.com

"It is a nightmare waking up every day wondering if some people halfway across the country will approve what my doctors have said is my only chance." 📄 New #PriorAuth in cancer report shows the scope of the problem & the need to #fixpriorAuth @cancercare.bsky.social www.cancercare.org/redtape

Better late than never I guess! Every year I try to write a review of the year just past, primarily for my grandkids to read when I’m no longer around and here is 2024 finally! runningintocancer.co.uk/2025/05/29/r...

Grateful to @ascocancer.bsky.social Ed Book 📗@n8pennell.bsky.social for this #MedEd publication 🛣️ How to move forward in #EarlyCareer 🚧 Overcoming barriers ⚙️ Switching gears ⏰ Making time and space 🔗: ascopubs.org/doi/10.1200/... @ericroeland.bsky.social @ryannipp.bsky.social

Special episode of GU Cast from Guy’s Hospital focused on #RadiationCystitis. Unique clinic dedicated to these unfortunate patients learn from Yasmin and Ramesh and team. Some great insights youtu.be/d4A2_swZOHw?...

Latest data on measles in the US. The total number of cases has already reached 800 in the first 4 months of 2025 with 85 hospitalizations and 3 deaths. There were 285 total cases last year. 🧪 www.cidrap.umn.edu/measles/us-m...

Ohio Medicaid got rid of big middlemen. Says it paid pharmacies a lot more — and saved $140M ohiocapitaljournal.com/2025/04/17/o...

What if we screened smarter, not just more? In BARCODE1, men with high polygenic risk (top 10%) had MRI + biopsy— 40% had prostate cancer. Over half needed treatment. Most would’ve been missed by PSA alone. Genetics is rewriting the rules. @nejm.org @myesmo.bsky.social @oncoalert.bsky.social

The act will disenfranchise vets/active/overseas military from voting as well (who often have less access to reams of documents) LDF Denounces House Passage of SAVE Act, Urges Senate to Reject Bill that Will Disenfranchise Millions of Americans - naacpldf.org/press-release/…#HellNoN#VotesForVetsts

Whatever fraud there is in Medicaid is largely on the provider side, not beneficiaries. It's health insurance, its not cash. "Fraud" here means going to a doctor if you are unemployed.

🚨 Hot off the press! 🚨 The @myesmo.bsky.social ESMO Precision Oncology Working Group, has unveiled key "Recommendations for structuring Molecular Tumour Boards (MTBs) in clinical practice", now published in ESMO's flagship journal Annals of Oncology 🧬🏥 www.annalsofoncology.org/article/S092...

Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study out on LANCET Oncology www.thelancet.com/journals/lan... These findings support the feasibility and effectiveness of large-scale lung cancer screening in a diverse population.

I understand this concern, but the anti-vaxx arguments are already everywhere on social media. We have to have people refuting this stuff. Can’t let it go completely unchecked.

Just in NIH grants, It looks like beautiful Iowa City, home of the U of Iowa, will lose $71m in funding. That's almost $1k per resident. And that's before all the other cuts to SSA, FDA, etc. Anyone in Iowa City that can offer more insight? scienceimpacts.org H/T to Prathima !

This is not efficiency, this is abandonment. Americans deserve health care that works for them — and instead, the Trump administration is wreaking havoc on seniors, people with disabilities, and our most vulnerable. In Illinois, we will stand up against these attacks.

The NIH is set to lose ~1,200 ppl as part of the HHS restructuring. An NIH researcher had not yet received news internally about plans to restructure the agency as of Thursday morning, less than an hour after Kennedy's statement published. cen.acs.org/policy/US-De... @cenmag.bsky.social #chemsky

Happy to share our new work with @haognguyen on targeting mRNA translation of oncogenes by RNA structure remodeling with a small molecule zotatifin. Congrats to ⁦@DuyguKuzuoglu⁩ an amazing postdoc and all the authors and collaborators! cell.com/cancer-cell/fu…

A friend drove two hours today for her breast cancer chemotherapy only to learn it was canceled due to NIH cuts. Clinical trial ended midstream. No treatment, no restart, no plan, no information. Her bro-in-law's chemo was also canceled.

"more transparency throughout [the #priorAuth] process is great, I remain concerned that relying on patients & physicians to recognize & initiate appeals places disproportionate burden on our patients who can least afford it." @michaelannica.bsky.social @ascocancer.bsky.social

Do these clinical trial failures demonstrate a failure of traditional pre-clinical models to reflect the human disease? In addition to the complete avoidance of biomarker-driven clinical trials to find the subset of patients that would benefit.? @asharpmedonc.bsky.social @pcf-science.bsky.social

Dr. Susan Slovin from MSK asks some key questions regarding #ProstateCancer #Immunotherapy @ascocancer.bsky.social ascopubs.org/doi/10.1200/...

Vaccines work. Measles, polio, smallpox—once devastating, now nearly gone. This is what science achieves when we trust it. Let’s not turn back. #VaccinesSaveLives #PublicHealth #ScienceMatters @statista.bsky.social

What a great day at our 2025 retreat- celebrating and socializing with colleagues and planning for the upcoming year. @marina-sharifi.bsky.social @noelleloconte.bsky.social @joshlangmd.bsky.social

Our new paper in JITC with a group of fine international friends, mentees and colleagues about immunotherapy in patients with cardiac metastasis. jitc.bmj.com/content/13/3/e… @danafarber.bsky.social jitc.bmj.com/content/13/3...64

Harrison, whose plasma contained a rare antibody, rolled up his sleeve 1,173 times from 1954 to 2018. The Australian is credited with helping 2.4 million babies and advancing scientific research.

Now online in Cancer Discovery: High-Purity Circulating Tumor Cell RNA Sequencing Identifies #ProstateCancer Lineage Phenotypes Prognostic for Clinical Outcomes - by Marina Sharifi, Jamie Sperger, Shuang Zhao, Joshua Lang, and colleagues doi.org/10.1158/2159...

Now online in Cancer Discovery: The Germline and Somatic Origins of #ProstateCancer Heterogeneity - by Takafumi Yamaguchi, Kathleen Houlahan, Helen Zhu, Natalie Kurganovs, Julie Livingstone, Natalie Fox, Niall Corcoran, Juri Reimand, Christopher Hovens, Paul Boutros, et al. doi.org/10.1158/2159...

Check out our latest preprint! Interested in Androgen Receptor, gene regulation and TRIM proteins? Well, in that case, I believe you’ll like this story! www.biorxiv.org/content/10.1...

Thanks for coming out today. A home game 🥰

Grateful for the invitation to give a seminar March 4 at UCLA! Hope to see those there with any interest in prostate cancer, androgen physiology or steroid metabolism! Any chance to talk science these days is particularly therapeutic and a distraction from the distractions. @dgsomucla.bsky.social 🧪

In science, we expand our knowledge & change our thinking through peer-reviewed, evidence based publications—it is what separates science from, well, political power grabs evidently trying to stop science. #FundScience #PublishScience #ShareScience

A tremendous program to inspire and train the next generation of biomedical researchers. No good comes from cancelling this program.

More tragic news about NIH and NIH science. Grant system is frozen and intramural program is being slashed. All will claw back on treatments and cures for cancer and other human diseases. This can’t be what the public wants. 🧪 www.science.org/content/arti...

New in Peru: 27 species previously undiscovered by science : Short Wave

NOW AVAILABLE: The 2024 State of Science Report, which summarizes the scientific presentations from the 2024 @PCFnews Annual Scientific Retreat! #PCFRetreat24 Download to learn about cutting-edge recent advances in #ProstateCancer research & treatment! www.pcf.org/stateofscien...

About $74 million in US govt funding (including NIH) went into developing enzalutamide - a multibillion dollar drug that prolonged life for countless men with prostate cancer. Why would anyone cut this support? We need more, not less! @ascocancer.bsky.social @theaacr.bsky.social

Just terrible.

Opportunities to cure are being missed. There would be an immediate impact if @ascocancer.bsky.social recommendations are implemented. @mcuban.bsky.social

PCF Science is now on BlueSky! Follow us for prostate cancer research news & building the prostate cancer research community.

#GU25 was an outstanding @ascocancer.bsky.social meeting: catching up with friends/ colleagues, watching mentees grow, learn up-to-date GU cancers management, and presenting a new HIF-2 inhibitor (casdatifan) data. Energized! The future is bright! @danafarber.bsky.social @jrgralow.bsky.social

So much fun moderating this session! @ascocancer.bsky.social

#PARP inhibitors in #ProstateCancer will again take center stage at #GU25 @ascocancer.bsky.social Here is refresher on some thoughts of the earlier data in #mCRPC ascopubs.org/doi/10.1200/...

There is even less biology/relevant biomarkers available in RWD that further exacerbates the data gap. Are we being pushed further from personalized medicine and personalized care? @ravimadan.bsky.social

One year ago, we launched the Cost Plus Marketplace to help healthcare businesses access affordable medications. Today, we proudly supply thousands of hospitals, clinics, long-term care facilities, surgery centers, and retail pharmacies. ➡️ Sign up today: business.costplusdrugs.com

The #GU25 abstracts are now available! Late-Breaking Abstracts (LBAs) will be released at 7:00 AM PT on their day of presentation. Check out the latest practice-changing science in GU cancers here: brnw.ch/21wQBxm Co-sponsored by @astro-org.bsky.social and Society of Urologic Oncology